Literature DB >> 29074644

Extracellular Signal-Regulated Kinase 1/2 Regulates Mouse Kidney Injury Molecule-1 Expression Physiologically and Following Ischemic and Septic Renal Injury.

Justin B Collier1, Rick G Schnellmann2.   

Abstract

The upregulation of kidney injury molecule-1 (KIM-1) has been extensively studied in various renal diseases and following acute injury; however, the initial mechanisms controlling KIM-1 expression remain limited. In this study, KIM-1 expression was examined in mouse renal cell cultures and in two different models of acute kidney injury (AKI), ischemia reperfusion (IR)-induced and lipopolysaccharide (LPS)-induced sepsis. KIM-1 mRNA increased in both AKI models, and pharmacological inhibition of extracellular signal-regulated kinase 1/2 (ERK1/2) signaling attenuated injury-induced KIM-1 expression in the renal cortex. Toll-like receptor 4 knockout (TLR4KO) mice exhibited reduced ERK1/2 phosphorylation and attenuated KIM-1 mRNA after LPS exposure. TLR4KO mice were not protected from IR-induced ERK1/2 phosphorylation and upregulation of KIM-1 mRNA. Following renal IR injury, phosphorylation of signal transducer and activator of transcription 3 (STAT3) at serine 727 and tyrosine 705 increased downstream from ERK1/2 activation. Because phosphorylated STAT3 is a transcriptional upregulator of KIM-1 and inhibition of ERK1/2 attenuated increases in STAT3 phosphorylation, we suggest an ERK1/2-STAT3-KIM-1 pathway following renal injury. Finally, ERK1/2 inhibition in naive mice decreased KIM-1 mRNA and nuclear STAT3 phosphorylation in the cortex, indicating homeostatic regulation of KIM-1. These findings reveal renal ERK1/2 as an important initial regulator of KIM-1 expression in IR and septic AKI and at a physiologic level.Visual Abstract.Proposed mechanism of IR, LPS, and ROS-induced renal damage that initiates ERK1/2 and STAT3 phosphorylation. STAT3 then binds to the KIM-1 promoter and increases KIM-1 mRNA. By preventing ERK1/2 phosphorylation following renal injury, STAT3 phosphorylation is decreased, leading to less phosphorylated STAT3 within the nucleus, and subsequently less KIM-1 mRNA increases post injury. U.S. Government work not protected by U.S. copyright.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 29074644      PMCID: PMC5698947          DOI: 10.1124/jpet.117.244152

Source DB:  PubMed          Journal:  J Pharmacol Exp Ther        ISSN: 0022-3565            Impact factor:   4.030


  42 in total

1.  Kidney injury molecule-1 (KIM-1), a putative epithelial cell adhesion molecule containing a novel immunoglobulin domain, is up-regulated in renal cells after injury.

Authors:  T Ichimura; J V Bonventre; V Bailly; H Wei; C A Hession; R L Cate; M Sanicola
Journal:  J Biol Chem       Date:  1998-02-13       Impact factor: 5.157

2.  Urinary kidney injury molecule-1: a sensitive quantitative biomarker for early detection of kidney tubular injury.

Authors:  Vishal S Vaidya; Victoria Ramirez; Takaharu Ichimura; Norma A Bobadilla; Joseph V Bonventre
Journal:  Am J Physiol Renal Physiol       Date:  2005-09-20

3.  Kidney injury molecule-1 outperforms traditional biomarkers of kidney injury in preclinical biomarker qualification studies.

Authors:  Vishal S Vaidya; Josef S Ozer; Frank Dieterle; Fitz B Collings; Victoria Ramirez; Sean Troth; Nagaraja Muniappa; Douglas Thudium; David Gerhold; Daniel J Holder; Norma A Bobadilla; Estelle Marrer; Elias Perentes; André Cordier; Jacky Vonderscher; Gérard Maurer; Peter L Goering; Frank D Sistare; Joseph V Bonventre
Journal:  Nat Biotechnol       Date:  2010-05       Impact factor: 54.908

4.  Toll-like receptor 4 is a key mediator of murine steatotic liver warm ischemia/reperfusion injury.

Authors:  Justin D Ellett; Zachary P Evans; Carl Atkinson; Michael G Schmidt; Rick G Schnellmann; Kenneth D Chavin
Journal:  Liver Transpl       Date:  2009-09       Impact factor: 5.799

5.  Shedding of kidney injury molecule-1, a putative adhesion protein involved in renal regeneration.

Authors:  Veronique Bailly; Zhiwei Zhang; Werner Meier; Richard Cate; Michele Sanicola; Joseph V Bonventre
Journal:  J Biol Chem       Date:  2002-07-23       Impact factor: 5.157

6.  Activation of p53 promotes renal injury in acute aristolochic acid nephropathy.

Authors:  Li Zhou; Ping Fu; Xiao R Huang; Fei Liu; Kar Neng Lai; Hui Y Lan
Journal:  J Am Soc Nephrol       Date:  2009-11-05       Impact factor: 10.121

7.  Kidney injury molecule-1 is a phosphatidylserine receptor that confers a phagocytic phenotype on epithelial cells.

Authors:  Takaharu Ichimura; Edwin J P V Asseldonk; Benjamin D Humphreys; Lakshman Gunaratnam; Jeremy S Duffield; Joseph V Bonventre
Journal:  J Clin Invest       Date:  2008-05       Impact factor: 14.808

8.  Delayed Mitogen-Activated Protein Kinase/Extracellular Signal-Regulated Kinase Inhibition by Trametinib Attenuates Systemic Inflammatory Responses and Multiple Organ Injury in Murine Sepsis.

Authors:  Joshua A Smith; Philip R Mayeux; Rick G Schnellmann
Journal:  Crit Care Med       Date:  2016-08       Impact factor: 7.598

9.  Tubular kidney injury molecule-1 in protein-overload nephropathy.

Authors:  Mirjan M van Timmeren; Stephan J L Bakker; Vishal S Vaidya; Veronique Bailly; Theo A Schuurs; Jeffrey Damman; Coen A Stegeman; Joseph V Bonventre; Harry van Goor
Journal:  Am J Physiol Renal Physiol       Date:  2006-02-07

10.  Expression and function of P-glycoprotein in a mouse kidney cell line.

Authors:  S Ernest; E Bello-Reuss
Journal:  Am J Physiol       Date:  1995-08
View more
  8 in total

1.  The MEK Inhibitor Trametinib Ameliorates Kidney Fibrosis by Suppressing ERK1/2 and mTORC1 Signaling.

Authors:  Petros Andrikopoulos; Julius Kieswich; Sabrina Pacheco; Luxme Nadarajah; Steven Michael Harwood; Caroline E O'Riordan; Christoph Thiemermann; Muhammad M Yaqoob
Journal:  J Am Soc Nephrol       Date:  2018-12-10       Impact factor: 10.121

2.  Extracellular signal-regulated kinase 1/2 regulates NAD metabolism during acute kidney injury through microRNA-34a-mediated NAMPT expression.

Authors:  Justin B Collier; Rick G Schnellmann
Journal:  Cell Mol Life Sci       Date:  2019-12-23       Impact factor: 9.261

3.  Intestinal Bacterial Translocation Contributes to Diabetic Kidney Disease.

Authors:  Hoang Thuy Linh; Yasunori Iwata; Yasuko Senda; Yukiko Sakai-Takemori; Yusuke Nakade; Megumi Oshima; Shiori Nakagawa-Yoneda; Hisayuki Ogura; Koichi Sato; Taichiro Minami; Shinji Kitajima; Tadashi Toyama; Yuta Yamamura; Taro Miyagawa; Akinori Hara; Miho Shimizu; Kengo Furuichi; Norihiko Sakai; Hiroyuki Yamada; Katsuhiko Asanuma; Kouji Matsushima; Takashi Wada
Journal:  J Am Soc Nephrol       Date:  2022-03-09       Impact factor: 14.978

4.  Myeloid-Derived Suppressor Cells Induce Podocyte Injury Through Increasing Reactive Oxygen Species in Lupus Nephritis.

Authors:  Dongya Zhang; Jingjing Xu; Jing Ren; Liang Ding; Guoping Shi; Dan Li; Huan Dou; Yayi Hou
Journal:  Front Immunol       Date:  2018-06-25       Impact factor: 7.561

5.  Renal glycosuria as a novel early sign of colistin-induced kidney damage in mice.

Authors:  Sophia L Samodelov; Michele Visentin; Zhibo Gai; Stephanie Häusler; Gerd A Kullak-Ublick
Journal:  Antimicrob Agents Chemother       Date:  2019-10-07       Impact factor: 5.191

6.  Leptin reduces in vitro cementoblast mineralization and survival as well as induces PGE2 release by ERK1/2 commitment.

Authors:  G Ruiz-Heiland; J W Yong; J von Bremen; S Ruf
Journal:  Clin Oral Investig       Date:  2020-08-20       Impact factor: 3.573

7.  KIM-1-mediated anti-inflammatory activity is preserved by MUC1 induction in the proximal tubule during ischemia-reperfusion injury.

Authors:  Mohammad M Al-Bataineh; Carol L Kinlough; Zaichuan Mi; Edwin K Jackson; Stephanie M Mutchler; David R Emlet; John A Kellum; Rebecca P Hughey
Journal:  Am J Physiol Renal Physiol       Date:  2021-06-21

8.  Kidney Injury Molecule-1 Is Upregulated in Renal Lipotoxicity and Mediates Palmitate-Induced Tubular Cell Injury and Inflammatory Response.

Authors:  Xueying Zhao; Xiaoming Chen; Yuanyuan Zhang; Jasmine George; Alyssa Cobbs; Guoshen Wang; Lingyun Li; Nerimiah Emmett
Journal:  Int J Mol Sci       Date:  2019-07-11       Impact factor: 5.923

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.